Int J Biol Sci
2022; 18(11):4466-4467.
doi:10.7150/ijbs.75760 This issueCite
Erratum
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
1. School of Medicine, Southeast University, Nanjing, China. 2. Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province, China. #These authors contributed equally to this work.
✉ Corresponding authors: Xuehao Wang, School of Medicine, Southeast University, Nanjing, China; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province, China. E-mail: wangxhedu.cn; Yue Yu, Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province, China; E-mail: yuyueedu.cn.More
Citation:
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760. https://www.ijbs.com/v18p4466.htm
Yang, R., Wang, D., Han, S., Gu, Y., Li, Z., Deng, L., Yin, A., Gao, Y., Li, X., Yu, Y., Wang, X. (2022). MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. International Journal of Biological Sciences, 18(11), 4466-4467. https://doi.org/10.7150/ijbs.75760.
ACS
Yang, R.; Wang, D.; Han, S.; Gu, Y.; Li, Z.; Deng, L.; Yin, A.; Gao, Y.; Li, X.; Yu, Y.; Wang, X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int. J. Biol. Sci. 2022, 18 (11), 4466-4467. DOI: 10.7150/ijbs.75760.
NLM
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760. https://www.ijbs.com/v18p4466.htm
CSE
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. 2022. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci. 18(11):4466-4467.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.